Lv1
40 积分 2023-09-04 加入
Proteomic Signatures of Vemurafenib Resistance in Canine Urothelial Carcinoma Harboring the BRAFV595E Mutation
23天前
已完结
Phase I/II Trial of Vemurafenib in Dogs with Naturally Occurring, BRAF-mutated Urothelial Carcinoma
23天前
已完结
Dermatological Adverse Events Associated With Lapatinib Treatment in Dogs With Urothelial Carcinoma: A Retrospective Study
23天前
已完结
Usefulness of squash preparation cytology in the diagnosis of canine urinary bladder carcinomas
24天前
已完结
855 Interim results from a comparative oncology safety study evaluating intravesical chitosan/interleukin-12 immunotherapy in client-owned dogs with invasive urothelial carcinoma
27天前
已完结
Proteomic Signatures of Vemurafenib Resistance in Canine Urothelial Carcinoma Harboring the BRAFV595E Mutation
27天前
已完结
Phase I/II Trial of Vemurafenib in Dogs with Naturally Occurring, BRAF-mutated Urothelial Carcinoma
27天前
已完结
Effective detection of BRAFV595E mutation in canine urothelial and prostate carcinomas using immunohistochemistry
27天前
已完结
Ultrasonographic findings related to prognosis in canine transitional cell carcinoma
27天前
已完结
Management of transitional cell carcinoma of the urinary bladder in dogs: a review
27天前
已完结
皖公网安备34019202002308
